Protagonist Therapeutics (PTGX) Total Liabilities (2015 - 2026)
Protagonist Therapeutics (PTGX) posted Total Liabilities of $42.0 million for Q1 2026, down 21.49% sequentially from $53.5 million in Q4 2025, and down 20.9% YoY from $53.1 million in Q1 2025.
Protagonist Therapeutics (PTGX) Total Liabilities (2015 - 2026) Analysis & Trends
Protagonist Therapeutics has reported Total Liabilities for 12 years, with the latest figure at $42.0 million in Q1 2026.
- Quarterly Total Liabilities fell 20.9% year-over-year to $42.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.0 million (down 20.9% YoY) and the FY2025 annual result came in at $53.5 million, down 22.97% from the prior year.
- Total Liabilities declined to $42.0 million in Q1 2026 per PTGX's latest filing, from $53.5 million in the prior quarter.
- Over five years, Total Liabilities peaked at $73.3 million in Q2 2024 and troughed at $21.3 million in Q4 2023.
- A 5-year average of $46.9 million and a median of $46.5 million in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities tumbled 49.07% in 2023, then jumped 226.36% in 2024.
- Over 5 years, Total Liabilities stood at $32.3 million in 2022, then sank by 34.18% to $21.3 million in 2023, then surged by 226.36% to $69.4 million in 2024, then declined by 22.97% to $53.5 million in 2025, then decreased by 21.49% to $42.0 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $42.0 million, $53.5 million, and $56.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | 44.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.00 Mn |
| Mar 31, 2026 | 41.99 Mn |
| Dec 31, 2025 | 53.48 Mn |
| Sep 30, 2025 | 56.25 Mn |
| Jun 30, 2025 | 49.99 Mn |
| Mar 31, 2025 | 53.08 Mn |
| Dec 31, 2024 | 69.43 Mn |
| Sep 30, 2024 | 71.94 Mn |
| Jun 30, 2024 | 73.31 Mn |
| Mar 31, 2024 | 68.83 Mn |
| Dec 31, 2023 | 21.27 Mn |
| Sep 30, 2023 | 27.87 Mn |
| Jun 30, 2023 | 26.40 Mn |
| Mar 31, 2023 | 23.69 Mn |
| Dec 31, 2022 | 32.32 Mn |
| Sep 30, 2022 | 38.56 Mn |
| Jun 30, 2022 | 42.53 Mn |
| Mar 31, 2022 | 46.52 Mn |
| Dec 31, 2021 | 47.67 Mn |
| Sep 30, 2021 | 43.52 Mn |